We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Gadolinium Nanotubes Enable MRI Tracking of Transplanted Stem Cells

By LabMedica International staff writers
Posted on 24 Nov 2010
The use of high contrast nanotubes are expected to increase the sensitivity of magnetic resonance imaging (MRI) to the point that this technique will be able to follow the movement of transplanted stem cells within the body of a patient.

The highly toxic rare earth element gadolinium is used in a chelated form as a contrast reagent for MRI. More...
A recent study has carried this use a step farther by sequestering the gadolinium inside carbon nanotubes. The resulting microscopic tubes are called "gadonanotubes,” and investigators at Rice University (Houston, TX, USA) have used them to label pig bone marrow-derived mesenchymal stem cells (MSCs).

They reported in the October 20, 2010, online edition of the journal Biomaterials that images produced using gadonanotubes were approximately 40 times brighter and clearer than traditional MRI images. In particular, the nanotubes readily entered and became concentrated in abnormal tissue such as tumors or damaged heart muscle. This level of sensitivity is such that it will allow tracking of labeled cells, such as stem cells, inside the body of a patient. The magnetic properties of gadolinium will allow the clinician to guide the nanoparticle-labeled cells to precise locations where they can be deposited and allowed to grow and differentiate.

"MRI images are 40 times clearer, brighter, and easier to read than before,” said senior author Dr. Lon Wilson, professor of chemistry at Rice University. "Until now, there has not been an effective way to track the cells within the body after they are delivered to the heart, and to test their effectiveness while they are in the heart.”

Related Links:
Rice University




New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
New
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Platelets sequester cfDNA during circulation (Murphy L. et al., Science, 2025; DOI: 10.1126/science.adp3971)

Platelets Could Improve Early and Minimally Invasive Detection of Cancer

Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.